- Traditional CMO is to provide pharmaceutical companies with the process development and API production services needed in the production of products. The “d” of cdmo is more emphasis on the process of customized R & D than CMO.
- After 2018, the price and profit of generic drugs were greatly reduced after the introduction of the policy of purchasing with quantity, and the transformation of pharmaceutical enterprises into innovative drugs was initially determined;
Traditional CMO is to provide pharmaceutical companies with the process development and API production services needed in the production of products. The “d” of cdmo is more emphasis on the process of customized R & D than CMO.
Compared with the traditional CMO business model, cdmo business technology innovation, project management and other comprehensive barriers are higher, more in line with the future development trend of the industry.
According to the statistics of Western Securities R & D center, in 2019, the scale of global cdmo industry is 79.8 billion US dollars, with a year-on-year growth of 13.19%.
With the gradual promotion of cdmo capacity transfer, the scale of China’s cdmo industry in 2019 will reach 44.1 billion yuan, with a year-on-year growth of 19.19%, far higher than the growth rate of global market scale.
With the transformation of large pharmaceutical enterprises, the number of entrepreneurial innovative pharmaceutical enterprises is also increasing rapidly. At present, it has gradually become one of the main forces of innovative drug research and development in China.
According to the public data, in 2019, the financing amount of domestic entrepreneurial and innovative pharmaceutical enterprises is close to 20 billion yuan, and the number of financing events has largely become an important driving force to promote the development of CMO industry in China.
On September 10, 2020, the “2020 China Pharmaceutical Health Industry Development Conference and the fourth China Pharmaceutical R & D and Innovation Summit (PDI)” announced the “2020 top 20 cdmo enterprises in China” (hereinafter referred to as “cdmo list”).
At present, the overall concentration of China’s cdmo industry is low, Cr5 (industry concentration) is less than 25%, which is because cdmo business is closely related to the development stage of the industry.
However, as time goes on, the transfer of overseas production capacity is accelerated, China’s pharmaceutical innovation and R & D as well as the improvement of cdmo enterprises’ own technical strength. It is expected that China’s cdmo industry concentration will continue to increase in the next few years.
Before 2018, the rapid development of solid preparation consistency evaluation and innovative drugs led to the rapid increase of domestic cro industry demand;
After 2018, the price and profit of generic drugs were greatly reduced after the introduction of the policy of purchasing with quantity, and the transformation of pharmaceutical enterprises into innovative drugs was initially determined;
During 2019, the growth of domestic cro service demand is mainly driven by the rapid growth of innovative drug R & D service demand. At the same time, the service demand of solid preparation consistency evaluation began to decline in 2019.
“Cdmo list” fully shows which enterprises have higher service level and which enterprises have better quality system.
For sale, buy peptides, purchase peptides, and buy peptides online, you can find the Chinese peptide company:
Shengnuo Biotechnology is a high-tech China polypeptide manufacturers,who has over 19 years experience for the biotechnology .Our Products involve peptide raw materials,polypeptide drug.
Our 0 defect has passed the FDA certification, and has become the first-class professional polypeptide drug and product development and large-scale production and export industry in China .
Our service scope：peptide synthesis、peptide hormones、peptide medicine、beauty peptide、peptide medicine product、peptide technology transfer、peptide technology service、peptide large-scale production、export of peptide
Thymopentin for Injection、 Thymalfasin for Injection 、 Bivalirudin 、Bulk Drug、 Liraglutide ……